AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18606504 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (10, 17.5 and 25 mg)
Number of subjects: 9
Study 18606504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 17225548 — intervention group
Group type: EXPERIMENTAL
Intervention: Qianggan capsule, 5 granules twice per day for 3 months
Number of subjects: 122
Study 17225548 — intervention group
Group type: COMPARATOR
Intervention: Tiopronin, 0.2 gram three times per day for 3 months
Number of subjects: 122
Study 12207143 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl during anesthesia
Number of subjects: 120
Study 12207143 — intervention group
Group type: COMPARATOR
Intervention: No fentanyl
Number of subjects: 120
Study 12207143 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 9695642 — intervention group
Group type: COMPARATOR
Intervention: Serum erythropoietin concentration in women with benign tumors
Number of subjects: 70
Study 9695642 — intervention group
Group type: COMPARATOR
Intervention: Serum erythropoietin concentration in women with malignant tumors
Number of subjects: 70
Study 9695642 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine or ovarian malignancy
Number of subjects: 70
Study 8581337 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide, 6 mg/kg
Number of subjects: 12
Study 8581337 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acetazolamide)
Number of subjects: 12
Study 2702851 — intervention group
Group type: EXPERIMENTAL
Intervention: bezafibrate (600 mg/day)
Number of subjects: 59
Study 2702851 — intervention group
Group type: COMPARATOR
Intervention: gemfibrozil (1200 mg/day)
Number of subjects: 59
Study 138608 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% retinoic acid derivative Ro 11-1430
Number of subjects: 31
Study 138608 — intervention group
Group type: COMPARATOR
Intervention: 0.05% retinoic acid (control)
Number of subjects: 31
Study 31882017 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 0
Study 31882017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 31882017 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 30216113 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with heart failure and LV dyssynchrony
Number of subjects: 31
Study 30216113 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic force ratio in patients
Number of subjects: 31
Study 30216113 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic force ratio in patients
Number of subjects: 31
Study 30216113 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 31
Study 27450625 — intervention group
Group type: EXPERIMENTAL
Intervention: SCORE2 recruitment techniques
Number of subjects: 0
Study 27450625 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-of-care treatments
Number of subjects: 0
Study 27450625 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly e-newsletter and communication by SCORE2 Executive Committee
Number of subjects: 0
Study 24184996 — intervention group
Group type: EXPERIMENTAL
Intervention: HHS (4 mL/kg)
Number of subjects: 36
Study 24184996 — intervention group
Group type: EXPERIMENTAL
Intervention: HES (7 mL/kg)
Number of subjects: 36
Study 24184996 — intervention group
Group type: COMPARATOR
Intervention: RL (7 mL/kg)
Number of subjects: 36
Study 22436836 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercisers (defined as women who met specific criteria for frequency: three times per week, duration: 20 minutes/session, intensity: moderate, mode: aerobic)
Number of subjects: 119
Study 22436836 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercisers
Number of subjects: 119
Study 22436836 — intervention group
Group type: COMPARATOR
Intervention: Nonexercisers
Number of subjects: 119
Study 22436836 — intervention group
Group type: COMPARATOR
Intervention: Exercisers and Nonexercisers
Number of subjects: 119
Study 19397392 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFAs
Number of subjects: 333
Study 17548446 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacy-enhancement exercise condition
Number of subjects: 26
Study 17548446 — intervention group
Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 26
Study 15304040 — intervention group
Group type: EXPERIMENTAL
Intervention: all-trans retinoic acid (ATRA)
Number of subjects: 25
Study 15304040 — intervention group
Group type: COMPARATOR
Intervention: chemotherapy
Number of subjects: 25
Study 12101335 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic shortening and plication of uterosacral ligaments with modified Gilliam suspension
Number of subjects: 31
Study 10431796 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (intact posterior capsule, posterior chamber monofocal IOL)
Number of subjects: 126
Study 10431796 — intervention group
Group type: COMPARATOR
Intervention: Group B (ruptured or removed posterior capsule, anterior chamber monofocal IOL)
Number of subjects: 126
Study 10431796 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy control eyes)
Number of subjects: 126
Study 7653813 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine 0.12 mg, morphine 0.2 mg, and hyperbaric tetracaine 12 mg intrathecally (EMT group, n = 11)
Number of subjects: 36
Study 7653813 — intervention group
Group type: COMPARATOR
Intervention: Morphine 0.2 mg and hyperbaric tetracaine 12 mg intrathecally (MT group, n = 13)
Number of subjects: 36
Study 7653813 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine 0.12 mg and hyperbaric tetracaine 12 mg intrathecally (ET group, n = 12)
Number of subjects: 36
Study 2696658 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunal infusion of nutrients at 1.3 kcal/min
Number of subjects: 6
Study 2696658 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunal infusion of nutrients at 3.3 kcal/min
Number of subjects: 6
Study 2696658 — intervention group
Group type: COMPARATOR
Intervention: Control (intragastric instillation of a 490 kcal, 400 ml, homogenized meal)
Number of subjects: 6
Study 414267 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine 25 mg
Number of subjects: 12
Study 414267 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine 75 mg
Number of subjects: 12
Study 414267 — intervention group
Group type: EXPERIMENTAL
Intervention: 95 dBA white noise
Number of subjects: 12
Study 414267 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine 25 mg + 95 dBA white noise
Number of subjects: 12
Study 414267 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine 75 mg + 95 dBA white noise
Number of subjects: 12
Study 31083198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocktail analgesic injection
Number of subjects: 36
Study 31083198 — intervention group
Group type: COMPARATOR
Intervention: Sterile saline
Number of subjects: 36
Study 28511086 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipelle biopsy (twice in the luteal phase prior to IVF)
Number of subjects: 111
Study 28511086 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention prior to IVF)
Number of subjects: 111
Study 28511086 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipelle biopsy
Number of subjects: 111
Study 28511086 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 111
Study 25790229 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatic arterial infusion (HAI) with 5-fluorouracil plus systemic antineoplastons (A10-I infusion followed by per-oral AS2-1)
Number of subjects: 65
Study 25790229 — intervention group
Group type: COMPARATOR
Intervention: Hepatic arterial infusion (HAI) with 5-fluorouracil alone (control arm)
Number of subjects: 65
Study 23987192 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 10
Study 23987192 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 10
Study 22052027 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf compression sleeves
Number of subjects: 14
Study 19884575 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT) exercise group (n = 19)
Number of subjects: 38
Study 19884575 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 38
Study 17576710 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 1000
Study 17576710 — intervention group
Group type: COMPARATOR
Intervention: Previous cataract surgery
Number of subjects: 1000
Study 17576710 — intervention group
Group type: COMPARATOR
Intervention: Barriers to cataract surgery
Number of subjects: 1000
Study 15107387 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander CPR (ByCPR) performed within two minutes
Number of subjects: 874
Study 15107387 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander CPR (ByCPR) performed after two minutes
Number of subjects: 874
Study 15107387 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnessed cardiac arrest
Number of subjects: 874
Study 11266479 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg-in-hole construct
Number of subjects: 30
Study 11266479 — intervention group
Group type: COMPARATOR
Intervention: End-to-end construct
Number of subjects: 30
Study 11266479 — intervention group
Group type: COMPARATOR
Intervention: V construct
Number of subjects: 30
Study 9043026 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus continuous infusion of 1 g m(‐2) day(‐1) fluorouracil for 5 days
Number of subjects: 200
Study 9043026 — intervention group
Group type: COMPARATOR
Intervention: RT alone (20 Gy in five daily fractions)
Number of subjects: 200
Study 9043026 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus fluorouracil
Number of subjects: 200
Study 9043026 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 200
Study 2022274 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal body temperature (BBT) scheduling
Number of subjects: 74
Study 2022274 — intervention group
Group type: COMPARATOR
Intervention: Luteinizing hormone (LH) monitoring scheduling
Number of subjects: 74
Study 6751456 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy with excision of the ulcer (HSV + E)
Number of subjects: 56
Study 6751456 — intervention group
Group type: COMPARATOR
Intervention: Billroth I partial gastrectomy (BI)
Number of subjects: 56
Study 29258584 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg tapentadol twice daily
Number of subjects: 60
Study 29258584 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg tapentadol twice daily
Number of subjects: 60
Study 29258584 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs or paracetamol
Number of subjects: 60
Study 24682378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage system (cell saver)
Number of subjects: 110
Study 24682378 — intervention group
Group type: COMPARATOR
Intervention: No cell saver
Number of subjects: 110
Study 24884670 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension vignette case with a Belgian patient (non-minority)
Number of subjects: 171
Study 24884670 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension vignette case with a Moroccan patient (minority)
Number of subjects: 171
Study 22800664 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating brackets
Number of subjects: 40
Study 22800664 — intervention group
Group type: COMPARATOR
Intervention: Conventional brackets
Number of subjects: 40
Study 22800664 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 20200419 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-wet-bonding
Number of subjects: 0
Study 20200419 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-wet-bonding
Number of subjects: 0
Study 20200419 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-overwet-bonding
Number of subjects: 0
Study 18342591 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing of operative photographic pictures
Number of subjects: 318
Study 18342591 — intervention group
Group type: COMPARATOR
Intervention: Not viewing operative photographic pictures
Number of subjects: 318
Study 15978304 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg plus insulin (PIO + INS)
Number of subjects: 289
Study 15978304 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus insulin (PLB + INS)
Number of subjects: 289
Study 12925332 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom Checklist
Number of subjects: 0
Study 10486687 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative use of narcotic analgesics
Number of subjects: 257
Study 10486687 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy
Number of subjects: 257
Study 10486687 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral buckling
Number of subjects: 257
Study 10486687 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined vitrectomy‐scleral buckling
Number of subjects: 257
Study 10369648 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (10 ppm)
Number of subjects: 10
Study 10369648 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 10
Study 10369648 — intervention group
Group type: COMPARATOR
Intervention: Prostacyclin PGI2
Number of subjects: 10
Study 1532551 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (150 micrograms)
Number of subjects: 24
Study 1532551 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (150 micrograms)
Number of subjects: 24
Study 1532551 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal sufentanil (IS)
Number of subjects: 24
Study 1532551 — intervention group
Group type: COMPARATOR
Intervention: Epidural sufentanil (ES)
Number of subjects: 24
Study 1532551 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IS and ES)
Number of subjects: 24
Study 2984332 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone, 1 g intravenously daily for 7 days
Number of subjects: 0
Study 2984332 — intervention group
Group type: COMPARATOR
Intervention: ACTH regime
Number of subjects: 0
Study 29627431 — intervention group
Group type: EXPERIMENTAL
Intervention: Pecs I (bupivacain 0.25%, 10mL) and Pecs II (bupivacain 0.25%, 20mL) block
Number of subjects: 54
Study 29627431 — intervention group
Group type: EXPERIMENTAL
Intervention: Pecs I and II blocks
Number of subjects: 54
Study 29627431 — intervention group
Group type: COMPARATOR
Intervention: Control group (no block treatment)
Number of subjects: 54
Study 29130615 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office bleaching using 40% hydrogen peroxide gel for one hour
Number of subjects: 40
Study 27018530 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Evaluative Conditioning (TEC) app
Number of subjects: 408
Study 27018530 — intervention group
Group type: COMPARATOR
Intervention: Control app
Number of subjects: 408
Study 24612524 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel volar plate (Trimed™ Volar Plate)
Number of subjects: 0
Study 24612524 — intervention group
Group type: COMPARATOR
Intervention: Titanium volar plate (Medartis® Aptus Volar Plate)
Number of subjects: 0
Study 24612524 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study 22819432 — intervention group
Group type: EXPERIMENTAL
Intervention: AMR101 4 g/day
Number of subjects: 702
Study 22819432 — intervention group
Group type: EXPERIMENTAL
Intervention: AMR101 2 g/day
Number of subjects: 702
Study 22819432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 702
Study 20435363 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant alleles at ‐509 and codons 10 and 25 of the TGFβ1 locus
Number of subjects: 1716
Study 20435363 — intervention group
Group type: COMPARATOR
Intervention: Unmatched analysis of 82 cases
Number of subjects: 1716
Study 20435363 — intervention group
Group type: COMPARATOR
Intervention: Unmatched analysis of 108 controls
Number of subjects: 1716
Study 18043103 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LPS), n = 113
Number of subjects: 226
Study 18043103 — intervention group
Group type: COMPARATOR
Intervention: Open surgery, n = 113
Number of subjects: 226
Study 16519092 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia patients
Number of subjects: 19
Study 16519092 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 19
Study 16519092 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study 12399287 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g extruded oat bran (11 g beta-glucan)
Number of subjects: 8
Study 12399287 — intervention group
Group type: COMPARATOR
Intervention: 75 g wheat bran (1 g beta-glucan)
Number of subjects: 8
Study 10550154 — intervention group
Group type: EXPERIMENTAL
Intervention: FU+LV (leucovorin-modulated fluorouracil)
Number of subjects: 2151
Study 10550154 — intervention group
Group type: COMPARATOR
Intervention: FU+LEV (fluorouracil and levamisole)
Number of subjects: 2151
Study 10550154 — intervention group
Group type: COMPARATOR
Intervention: FU+LV+LEV (fluorouracil, leucovorin, and levamisole)
Number of subjects: 2151
Study 7576933 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-3 (0.5, 1.0, 2.5, or 5.0 micrograms/kg/day)
Number of subjects: 0
Study 2072403 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual therapy format
Number of subjects: 80
Study 2072403 — intervention group
Group type: COMPARATOR
Intervention: Group therapy format
Number of subjects: 80
Study 2072403 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of patient's partner in therapy
Number of subjects: 80
Study 7347354 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper gastrointestinal 'skinny' endoscopy
Number of subjects: 125
Study 7347354 — intervention group
Group type: COMPARATOR
Intervention: Radiology
Number of subjects: 125
Study 30474700 — intervention group
Group type: EXPERIMENTAL
Intervention: SMOF-lipid
Number of subjects: 160
Study 30474700 — intervention group
Group type: COMPARATOR
Intervention: MCT/LCT
Number of subjects: 160
Study 28623918 — intervention group
Group type: EXPERIMENTAL
Intervention: gyejibokryung-hwan (GBH) or dangguijagyag-san (DJS)
Number of subjects: 116
Study 28623918 — intervention group
Group type: COMPARATOR
Intervention: Placebo granules
Number of subjects: 116
Study 26471036 — intervention group
Group type: COMPARATOR
Intervention: Annual immunologic fecal occult blood testing (I-FOBT)
Number of subjects: 0
Study 26471036 — intervention group
Group type: COMPARATOR
Intervention: Biennial immunologic fecal occult blood testing (I-FOBT)
Number of subjects: 0
Study 26471036 — intervention group
Group type: COMPARATOR
Intervention: No screening (control)
Number of subjects: 0
Study 23497529 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented training
Number of subjects: 30
Study 23497529 — intervention group
Group type: COMPARATOR
Intervention: Conventional hand exercises
Number of subjects: 30
Study 21355639 — intervention group
Group type: EXPERIMENTAL
Intervention: EX/RP therapy
Number of subjects: 30
Study 21355639 — intervention group
Group type: EXPERIMENTAL
Intervention: EX/RP therapy augmented by motivational interviewing strategies
Number of subjects: 30
Study 18799777 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Living Program (3 intervention modules of 5 sessions each)
Number of subjects: 270
Study 17292647 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg codeine
Number of subjects: 0
Study 17292647 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg codeine
Number of subjects: 0
Study 17292647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15494804 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 34
Study 15494804 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 34
Study 11561074 — intervention group
Group type: EXPERIMENTAL
Intervention: Enadoline (80 microg/70 kg)
Number of subjects: 8
Study 11561074 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol (1.5, 3, and 6 mg/70 kg)
Number of subjects: 8
Study 11561074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 11561074 — intervention group
Group type: EXPERIMENTAL
Intervention: Enadoline and Butorphanol
Number of subjects: 8
Study 9609980 — intervention group
Group type: EXPERIMENTAL
Intervention: Baghdadin device (direct current electrotherapy)
Number of subjects: 54
Study 9609980 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium stibogluconate
Number of subjects: 54
Study 9609980 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated lesions)
Number of subjects: 54
Study 7821310 — intervention group
Group type: EXPERIMENTAL
Intervention: L-acetylcarnitine (30 mg x kg)
Number of subjects: 22
Study 7821310 — intervention group
Group type: EXPERIMENTAL
Intervention: L-propionylcarnitine (30 mg x kg)
Number of subjects: 22
Study 7821310 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (1.25 mg i.v. bolus)
Number of subjects: 22
Study 7821310 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched subjects)
Number of subjects: 22
Study 3276389 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive care with combination chemotherapy
Number of subjects: 0
Study 3276389 — intervention group
Group type: COMPARATOR
Intervention: Supportive care
Number of subjects: 0
Study 29659478 — intervention group
Group type: EXPERIMENTAL
Intervention: Taekwondo training (TKD), 16 weeks, once a week for 60 min
Number of subjects: 30
Study 29659478 — intervention group
Group type: EXPERIMENTAL
Intervention: Taekwondo training (TKD)
Number of subjects: 30
Study 29098259 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM zirconia all‐ceramic crown
Number of subjects: 46
Study 29098259 — intervention group
Group type: COMPARATOR
Intervention: Cobalt‐chromium alloy porcelain‐fused‐to‐metal crown
Number of subjects: 46
Study 29098259 — intervention group
Group type: COMPARATOR
Intervention: Silver‐palladium alloy porcelain‐fused‐to‐metal crown
Number of subjects: 46
Study 26161468 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily communication and language therapy
Number of subjects: 0
Study 26161468 — intervention group
Group type: COMPARATOR
Intervention: Weekly therapy sessions
Number of subjects: 0
Study 22951075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric dual balloon
Number of subjects: 30
Study 22951075 — intervention group
Group type: COMPARATOR
Intervention: Diet and exercise alone (Control Group)
Number of subjects: 30